Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| NeuBase Therapeutics Inc | NBSE | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 0,4121 | 10:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,4121 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0,39 - 4,80 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 0,4121 | USD |
Finanzwerte NBSE
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 1,53M | 3,73M | - | 0 | -33,78M | -9,06 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News NeuBase Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 05.4.2024 | 22:05 | GlobeNewswire Inc. | NeuBase Therapeutics Announces Receipt of Notice from Nasdaq |
| 07.3.2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23.2.2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 26.1.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.1.2024 | 12:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28.12.2023 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28.12.2023 | 12:15 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 22.12.2023 | 12:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27.11.2023 | 15:00 | GlobeNewswire Inc. | Psychemedics Corporation Appoints Daniella Mehalik as VP -.. |
| 09.11.2023 | 22:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 06.11.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20.10.2023 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum NeuBase Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NBSE Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,43 | 0,45 | 0,411 | 0,4296484 | 23.711 | -0,0179 | -4,16% |
| 1 Monat | 0,4348 | 0,4653 | 0,39 | 0,4183446 | 50.322 | -0,0227 | -5,22% |
| 3 Monate | 0,671 | 1,15 | 0,39 | 0,754844 | 244.514 | -0,2589 | -38,58% |
| 6 Monate | 0,65 | 1,51 | 0,39 | 0,857935 | 295.240 | -0,2379 | -36,60% |
| 1 Jahr | 2,90 | 4,80 | 0,39 | 1,92 | 802.561 | -2,49 | -85,79% |
| 3 Jahre | 120,80 | 121,60 | 0,39 | 12,94 | 399.728 | -120,39 | -99,66% |
| 5 Jahre | 90,00 | 257,80 | 0,39 | 49,12 | 331.488 | -89,59 | -99,54% |
